Form 4: Surgery Partners Executive Acquires Shares Through Restricted Stock Awards

Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., acquired shares through restricted stock awards on February 28, 2024.

Summary

• Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., filed a Form 4 on March 1, 2024, reporting changes in beneficial ownership.
• On February 28, 2024, Brittenham acquired 2,886 shares of common stock at a price of $31.18 per share through restricted stock awards (RSAs) that vest in two equal annual installments beginning on the first anniversary of the grant date.
• Additionally, Brittenham acquired 7,697 shares of common stock at a price of $31.18 per share through RSAs that vest in three equal annual installments beginning on the first anniversary of the grant date.
• Following these transactions, Brittenham directly owns 41,052 shares of Surgery Partners, Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of shares by an executive is generally viewed as a positive, but it's not a major event.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The restricted stock awards vest over the next two to three years, incentivizing the executive to contribute to the company's long-term success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the executive's interests with the company's performance.

Key Dates